Skip to main content
Grassley calls for unannounced inspection of foreign drug plants
8/9/2019

Sen. Chuck Grassley, R-Iowa, says the FDA should conduct unannounced inspections of foreign manufacturing facilities, particularly those in China and India, where most ingredients used in US pharmaceuticals are made. "As you are aware, I believe that drug importation will help to reduce drug costs for American consumers and patients," Grassley wrote in a letter to FDA acting Commissioner Norman Sharpless and HHS Secretary Alex Azar, but he noted his "position is predicated on the FDA ensuring the safety and efficacy of those drugs."

Full Story: